dendriitrakkvaktsiine
Dendriitrakkvaktsiine, also known as dendritic cell vaccines, are a type of cancer immunotherapy that aims to stimulate the patient's immune system to recognize and attack cancer cells. This approach leverages the unique role of dendritic cells, which are professional antigen-presenting cells, in initiating and orchestrating immune responses.
The process typically involves isolating dendritic cells from a patient's blood. These cells are then cultured
Once loaded with tumor antigens, the activated dendritic cells are re-infused back into the patient. Their role
Dendriitrakkvaktsiine are considered personalized therapies because they are often derived from the patient's own cells and